BEAT
Dead / Cancelled — Cancelled — Section 8 (as of 15 Oct 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85718144
- Registration number
- 4446114
- Mark type
- Stylized text
- Filed
- 31 Aug 2012
- Published for opposition
- 24 Sept 2013
- Registered
- 10 Dec 2013
- Attorney of record
- Jonathan D. Reichman, Esq.
Goods and services
- Class 001 — Chemicals: Chemical products, namely, antibodies, heterodimeric antibodies and derivatives thereof, for use in the development or manufacture of immunological reagents for industrial and scientific use; antibodies, heterodimeric antibodies and derivatives thereof for laboratories, diagnostics and analytics for scientific or research use; chemical preparations for industrial and scientific use
- Class 005 — Pharmaceuticals: Medical preparations, namely, antibodies, heterodimeric antibodies and derivatives thereof, for the treatment of cancer, allergies, asthma, autoimmune diseases, inflammation, graft versus host diseases, inflammation, transplant rejection, infectious diseases, bone diseases, heart diseases, endocrine diseases, eye diseases, intestinal diseases and neurological diseases, in the form of parenteral, intravitreal, intra-peritoneal and aerosol therapies; medical preparations, namely, antibodies for diagnostic or therapeutic use and for use in assays
- Class 009 — Scientific and electric apparatus: Apparatus and instruments for scientific research including laboratory research in the field of antibodies, heterodimeric antibodies and derivatives thereof, all relating to research and laboratory practice
- Class 042 — Scientific and technological services: Medical services, namely, laboratory research in the field of antibodies, heterodimeric antibodies and derivatives thereof; human and veterinary services, namely, product development in the field of medicaments, namely, antibodies, heterodimeric antibodies and derivatives thereof; product development in the field of diagnostic and testing apparatus and instruments for the identification of diseases, namely, antibodies, heterodimeric antibodies and derivatives thereof; industrial research in the field of antibodies, heterodimeric antibodies and derivatives thereof; analysis of antibodies, heterodimeric antibodies and derivatives thereof in the nature of industrial analysis; contract research services in the field of antibodies, heterodimeric antibodies and derivatives thereof
Owner
- ICHNOS SCIENCES SA, CHEMIN DE LA COMBETA 5, CH
- Glenmark Pharmaceuticals S.A., La Chaux-de-Fonds, CH
- Glenmark Pharmaceuticals S.A., La Chaux-de-Fonds, CH
- Glenmark Pharmaceuticals S.A., La Chaux-de-Fonds, CH
Prosecution history
- 16 Oct 2021 — NOTICE OF CANCELLATION SEC. 8 EMAILED
- 15 Oct 2021 — CANCELLED SEC. 8 (6-YR)
- 14 Oct 2021 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 29 Apr 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Apr 2021 — POST REGISTRATION ACTION MAILED - SEC. 8
- 01 Apr 2021 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 01 Oct 2020 — POST REGISTRATION ACTION MAILED - SEC. 8
- 16 Sept 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jun 2020 — TEAS SECTION 8 RECEIVED
- 10 Dec 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Dec 2013 — REGISTERED-PRINCIPAL REGISTER
- 24 Sept 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Sept 2013 — PUBLISHED FOR OPPOSITION
- 04 Sept 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Aug 2013 — LAW OFFICE PUBLICATION REVIEW COMPLETED